Literature DB >> 9584964

Conditioning factors in drug abuse: can they explain compulsion?

C P O'Brien1, A R Childress, R Ehrman, S J Robbins.   

Abstract

There is a good deal of clinical evidence suggesting that compulsion to resume drug taking is an important part of the addiction syndrome. The symptoms comprising motivation to resume drug use, namely craving and compulsion, have been studied experimentally in human subjects. While much work remains to be done, there is evidence showing that these symptoms are influenced by learning. The research has been guided by animal studies demonstrating that drug effects can be conditioned. Much attention has been directed toward demonstrating the existence of drug conditioning in human addicts and exploring the neurological structures that may underlie such learned responses. We do not yet know the relative importance of learning in the overall phenomenon of relapse, and treatments based on conditioning principles are still under investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584964     DOI: 10.1177/026988119801200103

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  263 in total

1.  Alcohol craving and the dimensionality of alcohol disorders.

Authors:  K M Keyes; R F Krueger; B F Grant; D S Hasin
Journal:  Psychol Med       Date:  2010-05-12       Impact factor: 7.723

2.  Increased adult hippocampal neurogenesis is not necessary for wheel running to abolish conditioned place preference for cocaine in mice.

Authors:  M L Mustroph; J R Merritt; A L Holloway; H Pinardo; D S Miller; C N Kilby; P Bucko; A Wyer; J S Rhodes
Journal:  Eur J Neurosci       Date:  2014-11-13       Impact factor: 3.386

3.  Extinction of drug cue reactivity in methamphetamine-dependent individuals.

Authors:  Kimber L Price; Michael E Saladin; Nathaniel L Baker; Bryan K Tolliver; Stacia M DeSantis; Aimee L McRae-Clark; Kathleen T Brady
Journal:  Behav Res Ther       Date:  2010-05-19

Review 4.  Pharmacological enhancement of drug cue extinction learning: translational challenges.

Authors:  K M Kantak; B Á Nic Dhonnchadha
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

5.  Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.

Authors:  Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

6.  Compound stimulus presentation and the norepinephrine reuptake inhibitor atomoxetine enhance long-term extinction of cocaine-seeking behavior.

Authors:  Patricia H Janak; M Scott Bowers; Laura H Corbit
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

7.  An early attentional bias to BEGIN-stimuli of the smoking ritual is accompanied with mesocorticolimbic deactivations in smokers.

Authors:  Bastian Stippekohl; Bertram Walter; Markus H Winkler; Ronald F Mucha; Paul Pauli; Dieter Vaitl; Rudolf Stark
Journal:  Psychopharmacology (Berl)       Date:  2012-04-03       Impact factor: 4.530

8.  Neural correlates of specific and general Pavlovian-to-Instrumental Transfer within human amygdalar subregions: a high-resolution fMRI study.

Authors:  Charlotte Prévost; Mimi Liljeholm; Julian M Tyszka; John P O'Doherty
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

9.  Sex Differences in the Subcellular Distribution of Corticotropin-Releasing Factor Receptor 1 in the Rat Hippocampus following Chronic Immobilization Stress.

Authors:  Helena R McAlinn; Batsheva Reich; Natalina H Contoreggi; Renata Poulton Kamakura; Andreina G Dyer; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Neuroscience       Date:  2018-05-26       Impact factor: 3.590

10.  Phasic mesolimbic dopamine signaling encodes the facilitation of incentive motivation produced by repeated cocaine exposure.

Authors:  Sean B Ostlund; Kimberly H LeBlanc; Alisa R Kosheleff; Kate M Wassum; Nigel T Maidment
Journal:  Neuropsychopharmacology       Date:  2014-05-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.